In a report released today, Luke Sergott from Barclays maintained a Sell rating on Illumina (ILMN – Research Report), with a price target of ...

In a report released yesterday, Mason Carrico from Stephens maintained a Buy rating on Illumina (ILMN – Research Report), with a price target ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...

Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.

Effortlessly extract high-quality cfDNA with automated, next-generation sequencing-ready solutions tailored for neonatal ...

Illumina said it would continue to comply with all applicable laws and regulations wherever the company operates. "We remain focused on achieving high-single-digit revenue growth by 2027 ...

Beijing refrained from punishing big US household names, as it did when it retaliated against the Trump administration’s Feb 4 tariffs, but Illumina was the most high-profile company hit by the ...